2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions

Toxicology and Applied Pharmacology

Volumn 198, Issue 1, 2004, Pages 61-73

  LoPachin, Richard M ^a   He, Deke ^a   Reid, Maria L ^a   Opanashuk, Lisa A ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

2,5 Hexanedione; Axon atrophy; Distal axonopathy; Neurofilaments

Indexed keywords

ACETONYLACETONE; ANTIBODY; BETA TUBULIN; EPITOPE; MONOMER; NERVE PROTEIN; POLYMER; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; CONTROLLED STUDY; CYTOSKELETON; DYNAMIC EXERCISE; ELECTRICITY; EVALUATION; EXPOSURE; EXTRACTION; FRACTIONATION; IMMUNOBLOTTING; LUMBAR SPINE; MALE; MEASUREMENT; MOLECULAR WEIGHT; NERVE FIBER; NEUROFILAMENT; NEUROLOGIC DISEASE; NONHUMAN; PHOSPHORYLATION; PREVALENCE; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN INTERACTION; RAT; SEPARATION TECHNIQUE; SOLUBILITY; SPINAL CORD; SUPERNATANT; TOXICITY; VELOCITY; WHITE MATTER;

ADMINISTRATION, ORAL; ANIMALS; ATROPHY; AXONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEXANONES; LUMBOSACRAL REGION; MALE; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; NEUROTOXICITY SYNDROMES; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD DISEASES; SUBCELLULAR FRACTIONS;

EID: 2942739141     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.03.002     Document Type: Article

References (79)

1. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anerton B.H., Leigh P.N., Shaw C.E., Miller C.C.J. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161:2003;489-495
2. Anderson R.J., Dunham C.B. Electrophysiological deficits in peripheral nerve as a discriminator of early hexacarbon neurotoxicity. J. Toxicol. Environ. Health. 13:1984;835-843
3. Anthony D.C., Giangaspero F., Graham D.G. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3, 4-dimethyl-2, 5-hexanedione in the rat. J. Neuropathol. Exp. Neurol. 42:1983;548-560
4. Anthony D.C., Boekelheide K., Graham D.G. The effect of 3, 4-dimethyl substitution on the neurotoxicity of 2, 5-hexanedione: I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. Toxicol. Appl. Pharmacol. 71:1983;362-371
5. Baas P.W., Brown A. Slow axonal transport: the polymer transport model. Cell Biol. 7:1997;380-384
6. Braendgaard H., Sidenius P. Anterograde components of axonal transport in motor and sensory nerves in experimental 2, 5-hexanedione neuropathy. J. Neurochem. 47:1986;31-37
7. Brown M.J., DeJesus P.V., Pleasure D.E., Asbury A.K. Nerve conduction slowing precedes demyelination in experimental n-butyl ketone (MBK) neuropathy. Aguayo A., Kanpati G. Proceedings of the IVth International Congress on Neuromuscular Disease. 1978;276-301 Excerpta Medica, Amsterdam
8. Carden M.J., Lee V.M.-Y., Schalepfer W.W. 2, 5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. Neurochem. Pathol. 5:1986;25-35
9. Chen J., Nakata T., Zhang Z., Hirokawa N. The C-terminal tail domain of neurofilament protein-H NF-H) forms the crossbridges and regulates neurofilament bundle formation. J. Cell Sci. 113:2000;3861-3869
10. Chiu F.C., Norton W.T. Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J. Neurochem. 39:1982;1252-1260
11. Chiu F.C., Opanashuk L.A., He D.K., Lehning E.J., LoPachin R.M. γ-Diketone peripheral neuropathy: II. Neurofilament subunit content. Toxicol. Appl. Pharmacol. 165:2000;141-147
12. Cohlberg J.A., Hajarian H., Tran T., Alipourjeddi P., Noveen A. Neurofilament protein heterotetramers as assembly intermediates. J. Biol. Chem. 270:1995;9334-9339
13. DeCaprio A.P., Fowke J.H. Limited and selective adduction of carboxyl-terminal lysines in the high molecular weight neurofilament proteins by 2, 5-hexanedione in vitro. Brain Res. 586:1992;219-228
14. DeCaprio A.P., O'Neill E.A. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2, 5-hexanedione exposure. Toxicol. Appl. Pharmacol. 78:1985;235-247
15. DeCaprio A.P., Olajos E.J., Weber P. Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2, 5-hexanedione. Toxicol. Appl. Pharmacol. 65:1982;440-450
16. DeCaprio A.P., Strominger N.L., Weber P. Neurotoxicity and protein binding of 2, 5-hexanedione in the hen. Toxicol. Appl. Pharmacol. 68:1983;297-307
17. DeCaprio A.P., Kinney E.A., Fowke J.H. Regioselective binding of 2, 5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. Toxicol. Appl. Pharmacol. 145:1997;211-217
18. Elder G.A., Friedrich V.L., Margita A., Lazzarini R.A. Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit. J. Cell Biol. 146:1999;181-192
19. Eyer J., Leterrier J.-F. Influence of the phosphorylation state of neurofilament proteins on the interactions between purified filaments in vitro. Biochem. J. 252:1988;655-660
20. Gill J.L. Design and Analysis of Experiments in the Animal and Medical Sciences. 1978;Iowa State Univ. Press, Ames, IA
21. Gold B.G., Mobley W.C., Matheson S.F. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J. Neurosci. 11:1991;943-955
22. Gotow T., Tanaka J. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments. J. Neurosci. Res. 37:1994;691-713
23. Graham D.G., Anthony D.C., Boekelheide K., Maschmann N.A., Richards R.G., Wolfram J.W., Shaw B.R. Studies of the molecular pathogenesis of hexane neuropathy; II. Evidence that pyrrole derivitization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 64:1982;415-422
24. Graham D.G., Szakal-Quin G., Priest J.W., Anthony D.C. In vitro evidence that covalent crosslinking of neurofilaments occurs in γ-diketone neuropathy. Proc. Natl. Acad. Sci. 81:1984;4979-4982
25. Heimann R., Shelanski M.L., Liem R.K.H. Microtubule-associated proteins bind specifically to the 70-kDa neurofilament protein. J. Biol. Chem. 260:1985;12160-12166
26. Hirokawa N., Terada S., Funakoshi T., Takeda S. Slow axonal transport: the subunit transport model. Cell Biol. 7:1997;384-388
27. Horan K.I., Eichberg J., Berti-Mattera L.N., LoPachin R.M. Hexanedione effects on protein phosphorylation in rat peripheral nerve. Brain Res. 491:1989;366-370
28. Jacomy H., Zhu Q., Couillard-Despres S., Beaulieu J.-M., Julien J.-P. Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. J. Neurochem. 73:1999;972-984
29. Julien J.-P., Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257:1982;10467-10470
30. Jung C., Shea T.B. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ. Cell Motil. Cytoskeleton. 42:1999;230-240
31. Jung C., Yabe J.T., Wang F.-S., Shea T.B. Neurofilament subunits can undergo axonal transport without incorporation into Triton-insoluble structures. Cell Motil. Cytoskeleton. 40:1998;44-58
32. Jung C., Yabe J.T., Shea T.B. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res. 856:2000;12-19
33. Jung C., Yabe J.T., Lee S., Shea T.B. Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ. Cell Motil. Cytoskeleton. 47:2000;120-129
34. Karlsson J.-E., Rosengren L.E., Haglid K.G. Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2, 5-hexanedione. J. Neurochem. 57:1991;1437-1444
35. Lapadula D.M., Suwita E., Abou-Donia M.B. Evidence for multiple mechanisms responsible for 2, 5-hexanedion-induced neuropathy. Brain Res. 458:1988;123-131
36. Lehning E.J., Dyer K.S., Jortner B.S., LoPachin R.M. Axonal atrophy is a specific component of 2, 5-hexanedione peripheral neuropathy. Toxicol. Appl. Pharmacol. 135:1995;58-66
37. Lehning E.J., Jortner B.S., Fox J.H., Arezzo J.C., Kitano T., LoPachin R.M. γ-Diketone peripheral neuropathy: I. Quantitative morphometric analyses of axonal atrophy and swelling. Toxicol. Appl. Pharmacol. 165:2000;127-140
38. Leterrier J.F., Hartwig K.J., Vegners R., Janmey P.A. Mechanical effects of neurofilament cross-bridges. J. Biol. Chem. 271:1996;15687-15694
39. LoPachin R.M., DeCaprio A.P. Axon atrophy is the primary lesion of γ-diketone neuropathy: putative molecular mechanisms and pathophysiological implications. Toxicol. Appl. Pharmacol. 2004;. in press
40. LoPachin R.M., Lehning E.J. The relevance of axonal swelling and atrophy to γ-diketone neurotoxicity. Neurotoxicology. 18:1997;7-22
41. LoPachin R.M., Lehning E.J., Stack E.C., Hussein S.J., Saubermann A.J. 2, 5-Hexanedione alters elemental composition and water content of rat peripheral nerve myelinated axons. J. Neurochem. 63:1994;2266-2278
42. LoPachin R.M., Lehning E.J., Opanashuk L.A., Jortner B.S. Rate of neurotoxicant exposure determines morphological manifestations. Toxicol. Appl. Pharmacol. 167:2000;75-86
43. LoPachin R.M., Ross J.F., Reid M.L., Das S., Mansukhani S., Lehning E.J. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2, 5-hexanedione. Neurotoxicology. 23:2002;95-110
44. LoPachin R.M., Jortner B.S., Reid M.L., Das S. γ-Diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots. Toxicol. Appl. Pharmacol. 193:2003;29-46
45. Miyasaka H., Okabe S., Ishiguro K., Uchida T., Hirokawa N. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation of τ protein kinase II. J. Biol. Chem. 268:1993;22695-22702
46. Monaco S., Autilio-Gambetti L., Zabel D., Gambetti P. Giant axonal neuropathy. Acceleration of neurofilament transport in optic axons. Proc. Natl. Acad. Sci. 82:1985;920-924
47. Monaco S., Simonati A., Rizzuto N., Autilio-Gambetti L., Gambetti P. Hexacarbon axonopathy: the morphological expression of altered cytoskeletal translocation. Nappi G. Neurodegenerative Disorders: The Role Played by Endotoxins and Xenobiotics. 1988;239-251 Raven Press, New York
48. Monaco S., Autilio-Gambetti L., Lasek R.J., Katz M.J., Gambetti P. Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter. J. Neuropathol. Exp. Neurol. 48:1989;23-32
49. Monaco S., Jacob J., Jenich H., Autilio-Gambetti L., Gambetti P. Axonal transport of neurofilament is accelerated in peripheral nerve during 2, 5-hexanedione intoxication. Brain Res. 491:1989;328-334
50. Monaco S., Wongmongkolrit T., Shearson C.M., Patton A., Schaetzle B., Autilio-Gambetti L., Gambetti P., Sayre L.M. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport. Brain Res. 519:1990;73-81
51. Morris J.R., Lasek R.J. Stable polymers of the axonal cytoskeleton: the axoplasmic ghost. J. Cell Biol. 92:1982;192-198
52. Nachtman J.P., Couri D. Biophysical and electrophysiological studies of hexanedione neurotoxicity. Neurotoxicology. 2:1981;541-556
53. Nakagawa T., Chen J., Zhang Z., Kanai Y., Hirokawa N. Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and longitudinal elongation of filaments. J. Cell Biol. 129:1995;411-429
54. Nixon R.A. Dynamic behavior and organization of cytoskeletal proteins in neurons: reconciling old and new findings. BioEssays. 20:1998;798-807
55. Nixon R.A., Logvinenko K.B. Multiple fates of newly synthesized neurofilament proteins: evidence for a stationary neurofilament network distributed nonuniformly along axons of retinal ganglion cell neurons. J. Cell Biol. 102:1986;647-659
56. Nixon R.A., Lewis S.E., Marotta C.A. Posttranslational modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons. J. Neurosci. 7:1987;1145-1158
57. Nixon R.A., Paskevich P.A., Sihag R.K., Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing and axon caliber. J. Cell Biol. 126:1994;1031-1046
58. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250:1975;4007-4021
59. Okabe S., Miyasaka H., Hirokawa N. Dynamics of the neuronal intermediate filaments. J. Cell Biol. 121:1993;375-386
60. Opanashuk L.A., He D.K., Lehning E.J., LoPachin R.M. γ-Diketone peripheral neuropathy. III. Neurofilament gene expression. Neurotoxicology. 22:2001;215-220
61. Pyle S.J., Amarnath V., Graham D.G., Anthony D.C. Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2, 5-hexanedione. Cell Motil. Cytoskeleton. 26:1993;133-143
62. Sakaguchi T., Okada M., Kitamura T., Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci. Lett. 153:1993;65-68
63. Sayre L.M., Autilio-Gambetti L., Gambetti P. Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments. Brain Res. Rev. 10:1985;69-83
64. Shea T.B. Microtubule motors, phosphorylation and axonal transport of neurofilaments. J. Neurocytol. 29:2000;873-887
65. Shea T.B., Sihag R.K., Nixon R.A. Dynamics of phosphorylation and assembly of the high molecular weight neurofilament subunit in NB2a/d1 neuroblastoma. J. Neurochem. 55:1990;1784-1792
66. Shea T.B., Dahl D.C., Nixon R.A., Fischer I. Triton-soluble phosphovariants of the heavy neurofilament subunit in developing and mature mouse central nervous system. J. Neurosci. Res. 48:1997;515-523
67. Shea T.B., Jung C., Yabe J., Ma D.-L., Fischer I. Extensive phosphorylation and axonal transport of Triton-soluble neurofilament subunits. Herrmann H.D., Harris R.A. Subcellular Biochemistry. Intermediate Filaments. vol. 31:1998;Plenum, New York
68. Sickles D.W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. II. The effects of single doses of neurotoxic and non-neurotoxic diketones and b, b′-iminodipropionitrile (IDPN) on the rate and capacity of transport. Neurotoxicology. 10:1989;103-112
69. Sterman A.B. Hexacarbon neuropathy: cell body changes are early, dynamic and specific. Ann. Neurol. 16:1984;343-348
70. Takeda S., Okabe S., Funakaoshi T., Hirokawa N. Differential dynamics of neurofilament-H protein and neurofilament-L protein in neurons. J. Cell Biol. 127:1994;173-185
71. Terada M., Yasuda H., Kikkawa R., Koyama N., Yokota T., Shigeta Y. Electrophysiological study of dorsal column function in streptozotocin-induced diabetic rats: comparison with 2, 5-hexanedione intoxication. J. Neurol. Sci. 115:1993;58-66
72. Towbin H., Stachelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354
73. Tsuda M., Tashiro T., Komiya Y. Increased solubility of high-molecular-mass neurofilament subunit by suppression of dephosphorylation: its relation to axonal transport. J. Neurochem. 68:1997;2558-2565
74. Watson D.F., Fittro K.P., Hoffman P.N., Griffin J.W. Phosphorylation- related immunoreactivity and the rate of transport of neurofilaments in chronic 2, 5-hexanedione intoxication. Brain Res. 539:1991;103-109
75. Wong J., Hutchison S.B., Liem R.K.H. An isoelectric variant of the 150, 000-dalton neurofilament polypeptide. J. Biol. Chem. 259:1984;10867-10874
76. Yabe J.T., Jung C., Chan W.K.-H., Shea T.B. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil. Cytoskeleton. 45:2000;249-262
77. Yabe J.T., Chylinski T., Wang F.-S., Pimenta A., Katter S.D., Linsley M.-D., Chan W.K.-H., Shea T.B. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J. Neurosci. 21:2001;2195-2205
78. Yabe J.T., Chan W.K.-H., Chylinski T., Lee S., Pimenta A., Shea T.B. The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation and maturation. Cell Motil. Cytoskeleton. 48:2000;61-83
79. Yagi Y. Effects of 2, 5-hexanedione on rat spinal pyramidal tract. Jpn. J. Ind. Health. 36:1994;173-180